Hematogen Fa

Quick links to important sections

Hematogen Fa

Selected form

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Hematogen Fa

What is Hematogen Fa?

Hematogen Fa is an oral therapeutic agent formulated to address specific nutritional deficiencies related to red blood cell production. It is classified as a hematinic, a category of substances that work to increase the hemoglobin content and the total number of erythrocytes in the blood.

Composition and Mechanism

The formulation typically consists of a combination of essential nutrients that play a critical role in erythropoiesis (the process of producing red blood cells). The primary components usually include:

  • Iron: A vital mineral required for the synthesis of hemoglobin, the protein in red blood cells responsible for transporting oxygen throughout the body.
  • Vitamin B12 (Cyanocobalamin): An essential vitamin necessary for proper DNA synthesis and the maturation of red blood cells.
  • Folic Acid: A B-vitamin that works in conjunction with Vitamin B12 to support the production of healthy red blood cells.
  • Vitamin C (Ascorbic Acid): Often included to enhance the gastrointestinal absorption of iron.

Therapeutic Purpose

Hematogen Fa is primarily used to manage and prevent various forms of anemia, particularly those resulting from iron deficiency or megaloblastic conditions where the body lacks sufficient folate or Vitamin B12. By providing these specific building blocks, the supplement helps the body maintain adequate oxygen-carrying capacity and supports metabolic functions associated with cellular growth and repair.

Regulatory References

  1. NIH: Iron, Folate, and B12 in Blood Cell Synthesis
  2. NIH MedlinePlus on Anemia

What side effects are possible with Hematogen Fa?

Possible Side Effects and Safety Information

The official safety profile for this combination medicine is structured around common gastrointestinal effects, specific population warnings, and restrictions related to diagnosis. The classification of adverse reactions varies in regulatory documents but often uses terms such as Rare or Not Known frequency.

Adverse Reactions by System-Organ Class

The most commonly listed adverse reactions affect the Gastrointestinal System, including Nausea, Vomiting, Constipation, Diarrhoea, and Abdominal Pain. Oral iron preparations are documented to cause the expected effect of Dark-Coloured Stool. Reactions concerning the Immune System, such as general Hypersensitivity and rare reports of Anaphylactic Reaction, are also included in official labels.

Serious Adverse Reactions

Regulatory agencies consistently highlight the critical risk of Accidental Overdose of Iron-containing products, which is cited as a leading cause of fatal poisoning in children younger than six years of age. A long-term safety concern documented in official summaries is Haemosiderosis (iron overload), which may result from excessive or mistaken prolonged therapy.

Safety Considerations and Restrictions

Specific safety statements address certain populations and conditions. For patients with suspected Vitamin B₁₂ deficiency, the Folic Acid component must be noted, as it may produce a hematologic response while masking the neurological manifestations of an underlying B₁₂ deficiency. Furthermore, the presence of the iron component in the body may interfere with laboratory tests used for the detection of occult blood in the stools. The gastrointestinal effects are frequently noted as transient or temporary, often diminishing as the body adjusts to the medication.

Overdose and Emergency Response

Overdose and When to Seek Help

The official overdose profile for Hematogen Fa, a combination product containing iron (Ferrous Fumarate), is defined by the acute toxicity of the iron component. Government regulatory documents categorize acute iron overdose as a potentially fatal medical emergency that requires immediate intervention.

Documented Overdose Manifestations

Initial signs of overdose, typically within the first six hours, include severe gastrointestinal symptoms such as vomiting, diarrhea, and abdominal pain. These symptoms may be followed by a temporary quiescent phase before progression to severe systemic toxicity. Late or severe manifestations involve the cardiovascular and hepatic systems, characterized by shock, hypotension, severe metabolic acidosis, and potential liver failure.

When to Seek Urgent Medical Help

Immediate medical attention or contact with emergency services is required for any suspected or accidental overdose of Hematogen Fa. Accidental overdose of iron-containing products is specifically cited in regulatory warnings as a leading cause of fatal poisoning in children under 6 years of age. Regulatory guidance mandates calling a Poison Control Center immediately, regardless of whether initial symptoms are mild or absent.

Official Management Procedures

Management involves continuous hospital monitoring of serum iron concentration and vital signs. The specific antidote for severe iron intoxication, deferoxamine mesylate, is officially recognized for use in chelation therapy. Supportive treatment includes intravenous fluid resuscitation and procedures such as whole-bowel irrigation may be required.

Therapeutic Uses of Hematogen Fa

What Hematogen FA Treats: Main Uses and Benefits

The primary purpose of Hematogen FA is to serve as a nutritional supplement used for managing deficiencies in key blood-forming nutrients; this type of product is relevant for addressing nutritional imbalances.

Hematogen FA is specifically applied in addressing conditions involving a lack of iron and/or B-vitamins, which may be part of symptomatic management for various forms of anemia. This preparation is commonly used to help with conditions presenting with systemic or localized discomfort, such as managing symptoms that interfere with daily functioning and those related to heightened physiological activity.

The product contributes to easing the overall symptom load associated with Iron Deficiency, Vitamin B9 and B12 Deficiency, and is considered relevant during pregnancy for patients who experience symptoms related to systemic imbalance. It is commonly used when symptoms intensify and supportive relief is needed, as it supports general well-being during symptomatic phases of convalescence. The supportive relief helps maintain a sense of stability when symptoms are more noticeable.

The preparation is relevant for easing symptoms across condition categories that involve episodic or fluctuating manifestations, commonly including deficiencies related to anemia, nutritional imbalance, and convalescence.

Applied in addressing Symptoms Related to Systemic Imbalance

Regulatory References

  1. DailyMed - IRON FOLATE PLUS capsule overview

Eligibility and Restrictions for Use

Hematogen Fa, a prescription supplement containing iron (ferrous fumarate), Vitamin C, Vitamin B12, and folic acid, is typically indicated for the prevention and treatment of anemias responsive to oral iron therapy. This often includes iron-deficiency anemia associated with pregnancy, chronic or acute blood loss, dietary restrictions, or metabolic disease.

However, certain individuals should not use this product due to the risk of serious complications, primarily related to iron overload or masking a critical blood disorder.


Contraindications

Condition Reason for Contraindication
Iron Overload Syndromes (Hemochromatosis, Hemosiderosis) Risk of toxic accumulation of iron in organs.
Pernicious Anemia (Untreated Vitamin B12 deficiency) Folic acid can correct blood abnormalities but allow irreversible nerve damage to continue undetected.
Known Hypersensitivity Allergy to any of the product's components.

Important Safety Information

Patients should inform their healthcare provider about their full medical history, especially if they have stomach or intestinal problems (like ulcers or colitis) or a history of alcohol abuse. Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under six. This product should be kept out of reach of children at all times.

What should I know about interactions with other medicines?

Hematogen Fa Interactions with other medicines and products

Official government regulatory information outlines several clinically significant interactions involving the components of this product, primarily relating to altered absorption or reduced drug activity.


Interaction Scope

Category Regulatory Statement Basis
Medicinal product categories with documented interactions: Bisphosphonates, Quinolone antibiotics, Tetracycline antibiotics, Thyroid medications, Anti-seizure drugs (e.g., phenytoin), Antacids, Anti-parkinsonian agents (Levodopa).
Mechanistic basis of interactions: The iron salts component can decrease the absorption of co-administered drugs due to chelate formation in the gastrointestinal tract. The Ascorbic Acid component has been linked to complex formation with certain antiviral agents.

Official Interaction Statements

The iron component may cause a decreased therapeutic effect of Levodopa and requires separation of administration times by as much as possible due to chelation. Co-administration can also decrease the absorption of a range of medicines, including alendronate, levofloxacin, doxycycline, and levothyroxine. The Ascorbic Acid (Vitamin C) component may result in decreased Bortezomib activity through complex formation, and patients are constrained to avoid starting Vitamin C supplements without consulting their prescriber.

Mechanism of Action

How Hematogen Fa Works

DNA Synthesis Support and Erythrocyte Maturation

The mechanism addresses cell proliferation by supplying the essential cofactors, Folic Acid and Cyanocobalamin, required for the one-carbon metabolism pathway. Cyanocobalamin helps recycle folate into its active form, Tetrahydrofolate (THF), which is crucial for synthesizing the DNA bases required for cell division. This mechanism provides the components necessary for the bone marrow to produce normal-sized, mature erythrocytes (red blood cells), resolving the underlying proliferation defect.


Heme Substrate Provision and Oxygen Transport

This mechanism involves the direct supply of the metallic component, Ferrous Fumarate, which is utilized by developing red blood cells for heme synthesis. The iron atom is structurally integrated into the protoporphyrin ring to form Hemoglobin, the protein responsible for binding and releasing oxygen. This action supports the formation of newly formed red blood cells that are iron-replete (normochromic), which supports the blood's oxygen-carrying capacity.


Bioavailability Facilitation Mechanism

This third action is a chemical facilitation provided by Sodium Ascorbate (Vitamin C), which acts as a powerful reducing agent in the gut. By converting poorly absorbed ferric iron (Fe^3+) into the readily absorbed ferrous iron (Fe^2+), this component maximizes the bioavailability and delivery of the iron substrate to the systemic circulation. This facilitates the iron supply mechanism to the hematopoietic tissues.

Dosage and Administration Information

How to Use Hematogen Fa: Official Administration Guidelines

Hematogen Fa is an oral medicine, and its correct usage is based on established dosing principles for iron and B-vitamin combinations.

Approved Route, Forms, and Intake Conditions

Feature Official Instruction
Route of Administration Exclusively Oral (taken by mouth).
Available Forms Tablet, Capsule, and Syrup formulations exist.
Timing Relative to Food Ideally taken on an empty stomach (1 hour before or 2 hours after a meal) for optimal absorption. It may be taken with food if needed to reduce potential gastrointestinal discomfort.

Standard Dosing and Duration

Official dosing is based on the therapeutic purpose:

  • Prophylactic Use (Prevention): The standard adult dose is typically one dose unit (e.g., one tablet or capsule) once daily.
  • Therapeutic Use (Treatment): For correcting an established deficiency, the dose is generally higher, ranging from one to three dose units daily.

Therapeutic regimens often require a minimum course of 4 to 6 months to ensure that not only are hematological parameters normalized, but body iron stores are also fully replenished.

Special Administration Instructions

  • Solid Forms: Tablets and capsules must be swallowed whole and should not be crushed or chewed, a common instruction for these dosage types.
  • Pediatrics: The syrup formulation is the preferred choice for children, as it allows for precise, weight-based dose measurement.
  • Co-ingestion Constraint: The dose should be separated by at least two hours from substances known to interfere with iron absorption, such as dairy products, tea, and coffee.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Hematogen Fa


Evidence for use in Anemia associated with Chronic Kidney Disease (CKD)

Research has examined Hematogen Fa in adults with conditions characterized by functional limitations, specifically anemia associated with Chronic Kidney Disease (CKD). Studies explored how Hematogen Fa was evaluated for its association with changes in hemoglobin levels and patient-reported outcomes, which is a key outcome related to systemic or functional imbalance. The types of studies conducted include randomized controlled trials and observational studies, where researchers monitored patient experiences over defined time intervals. Findings describe patterns observed in the studies where participants taking Hematogen Fa was associated with changes in their hemoglobin levels as measured during the study period. While research suggests short-term changes, follow-up durations were limited in many studies, and comparative evidence is not yet comprehensive enough to fully understand all patterns observed.


Evidence for use in Chemotherapy-Induced Anemia (CIA)

Hematogen Fa was evaluated in patients with anemia caused by specific types of chemotherapy. The use of Hematogen Fa was studied for its impact on patterns observed related to the need for red blood cell transfusions, which is an important outcome describing episodic or acute changes. Studies focused on research exploring short-term symptom changes during and immediately following chemotherapy cycles, and data show patterns related to how the need for transfusions evolved in the observed populations. However, results apply only to the populations studied, and subgroup findings are uncertain regarding patterns in research involving different patient groups.


What is Still Uncertain about Hematogen Fa

This section synthesizes the main evidence gaps. The current evidence contributes to understanding symptom patterns but long-term effects are not fully established. Available data mainly reflect shorter follow-up periods, meaning that there is limited information for long-term outcomes. Additionally, research on the observed patterns in children is very limited, and data for certain other groups remain insufficient. Continuous research is needed to fill these gaps and clarify areas where findings were mixed.

Frequently Asked Questions (FAQ)

Common questions about Hematogen Fa (FAQ)


Q: Is Hematogen Fa the same as regular iron supplements?

No, Hematogen Fa is not the same as a regular iron supplement. It is a fixed-dose combination that contains four essential components: iron, Vitamin C, Vitamin B₁₂, and Folic Acid. Most standard iron supplements contain only a single form of iron.

Q: Why is Hematogen Fa sometimes described as a 'blood builder'?

This description reflects the product's function as an antianemic agent (or hematinic). It supplies the essential substrates, including iron, folate, and Vitamin B₁₂, that the body needs for red blood cell production, and this action is described as helping in the formation of healthy blood cells.

Q: Is Hematogen Fa used for low energy or tiredness?

Hematogen Fa is indicated for treating and preventing anemias that respond to oral iron therapy. Anemia is a condition commonly associated with symptoms like tiredness and low energy. The product's purpose is to provide the necessary components to correct the underlying deficiency, and such correction is described as being associated with the alleviation of these symptoms.

Q: Is Hematogen Fa available over the counter?

The availability of this fixed-dose combination often depends on its exact strength and the local regulations of the governing health authority. While many iron and B-vitamin combinations are sold without a prescription, the specific status (prescription or over-the-counter) of Hematogen Fa is defined by the official labeling of the local health authority.

Q: How quickly do people typically expect to notice effects from Hematogen Fa?

The time it takes to notice improvement can vary widely among individuals. While symptoms like tiredness may begin to improve within a few weeks of starting treatment, official guidelines emphasize that the full process of replenishing body iron stores requires a minimum treatment course of 4 to 6 months.

Q: Is it normal to feel a change in appetite while taking Hematogen Fa?

Yes, official safety information for products containing iron and folic acid often lists a loss of appetite as a possible side effect.

Q: Are the side effects of Hematogen Fa generally mild or severe?

Side effects cover a range. The most commonly reported side effects are gastrointestinal, such as nausea, constipation, or diarrhea, which are often mild and may be temporary. However, regulatory documents also include serious warnings about the risk of severe allergic reactions and fatal poisoning from accidental overdose in children.

Q: What happens if a dose of Hematogen Fa is missed?

Official guidance for products with this composition typically describes the general approach, which is to resume the regular schedule and advise against taking two doses at once. The information generally advises against taking two doses at once.

Q: Are there any known interactions between Hematogen Fa and common pain relievers?

Interaction information for the Folic Acid component does not typically list specific risks with simple pain relievers such as Paracetamol. However, regulatory documents describe that when combined with certain medications like Methotrexate, the co-administration of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) such as Ibuprofen is a concern that requires professional guidance.

Q: Is Hematogen Fa safe for long-term use?

Therapeutic use requires a minimum course of 4 to 6 months to replenish iron stores. However, prolonged, excessive, or mistaken use carries a risk of Haemosiderosis (iron overload), a serious long-term safety concern documented in product labels. The protocol described in clinical guidelines is that ongoing use requires professional supervision.

Q: Does alcohol interact negatively with Hematogen Fa?

Regulatory safety information lists a history of alcohol abuse as a medical detail that should be discussed with a healthcare provider prior to use. The chronic use of alcohol can affect the way the body uses iron and vitamins, which is why this information is medically relevant for the prescriber.

Q: Can vitamins and supplements interfere with Hematogen Fa?

Yes, official labeling notes that other substances can interfere with the components of Hematogen Fa. For example, supplements containing Zinc or high doses of Vitamin C may be constrained in certain patients. Iron can also decrease the absorption of certain thyroid medications and antibiotics.

Q: What do official sources say about using Hematogen Fa during pregnancy?

The product is officially indicated for the prevention and treatment of iron-deficiency anemia that is associated with pregnancy. The specific use protocol is managed by the prescribing healthcare professional.

Q: Is Hematogen Fa suitable for use while breastfeeding?

Official safety information for the active components (iron, B₁₂, and folate) indicates that they are normal components of human milk. These ingredients are often supplemented during lactation to ensure the mother meets recommended intake levels. The final determination regarding use during lactation is within the scope of a healthcare professional's assessment.

Q: Can children take Hematogen Fa?

Yes, children can take Hematogen Fa; the syrup formulation is preferred for children to allow for precise, weight-based dosing. However, due to the critical risk involved, regulatory agencies cite accidental overdose of iron-containing products as a leading cause of fatal poisoning in children under six years of age. Official product information, therefore, includes mandatory warnings that the product must be kept out of the reach of children.

Q: What is the recommended age range for using Hematogen Fa?

While the product is used across various age groups, specific dosing guidelines are provided for children of varying ages, adolescents, and adults. The precise dose and suitability for a specific age group is managed by the healthcare professional.

Q: Is there a different formulation of Hematogen Fa for older adults?

Official product labeling lists tablet, capsule, and syrup formulations. There is no specific formulation designated only for older adults. However, the syrup form is available and is a type of formulation that is typically considered when a patient experiences difficulty swallowing solid forms.

Q: Is Hematogen Fa a drug that treats anemia directly?

Hematogen Fa is classified as an antianemic agent. It works by supplying the essential substrates and cofactors (iron, B₁₂, and folate) that the body requires to synthesize its own healthy red blood cells. Its function is to provide the necessary materials for blood production.

Q: What makes Hematogen Fa different from other products containing iron and folate?

Hematogen Fa is a specific fixed-dose combination that includes Vitamin B₁₂ (Cyanocobalamin) and Vitamin C (Sodium Ascorbate), in addition to the standard iron and folate. The Vitamin C component is included to enhance the absorption of the iron.

Q: Are there different strengths of Hematogen Fa available?

The product is usually manufactured in standard 'dose units,' such as one tablet or capsule. While the therapeutic dose prescribed by a physician may vary, regulatory documents do not typically describe the availability of multiple different standardized strengths of the dose unit itself.

Q: Does the time of day matter when taking Hematogen Fa?

Official guidelines describe that taking the product at the same time each day aids consistency. The specific time of day (morning or evening) is generally not mandated, provided the mandatory constraint regarding separation from food and drinks like coffee, tea, or dairy is followed.

Q: What specific ingredients in Hematogen Fa are responsible for the 'Fa' component?

The 'Fa' component in the product name is derived from Folic Acid, which is one of the four active ingredients. Folic Acid is a B-vitamin necessary for healthy cell division and blood formation.

Q: Is the research evidence for Hematogen Fa considered strong or limited?

Research evidence includes studies such as randomized controlled trials and observational studies that suggest short-term changes in specific patient groups. However, regulatory summaries note that comparative evidence is not yet comprehensive, and information on long-term outcomes and effects in children is limited.

Q: What is the chemical name of the active ingredient in Hematogen Fa?

Hematogen Fa contains four active ingredients. The chemical names used in official documents are Ferrous Fumarate, Cyanocobalamin (Vitamin B₁₂), Folic Acid, and Sodium Ascorbate (Vitamin C).

Q: Is a patient required to have blood tests while using Hematogen Fa?

While regulatory documents do not provide personal clinical advice, official clinical guidelines for the management of B₁₂ and folate deficiencies often require blood tests. These tests are performed to confirm the initial diagnosis and to monitor the body’s therapeutic response to the replacement treatment.

Q: Are there official guidelines for stopping Hematogen Fa?

Official guidelines for treating deficiencies emphasize that treatment is often long-term and must be continued to prevent symptoms from returning. The regulatory protocol is that the discontinuation or adjustment of the regimen is determined by a healthcare provider following a re-evaluation of the underlying deficiency.

Q: Does Hematogen Fa have a known effect on sleep?

Official product labels generally do not list sleep-related issues as common adverse reactions. However, one of the components, Vitamin B₁₂, is known to play a physiological role in the body’s regulation of the sleep-wake cycle.

Q: Does Hematogen Fa have a risk of dependence or withdrawal?

Hematogen Fa is composed of essential vitamins and minerals. Official health committee documents state that these types of products are not associated with the pharmacological risks of dependence or withdrawal that are documented for controlled substances.

Q: What does the patient leaflet say about driving while taking Hematogen Fa?

Official product information for fixed-dose iron and vitamin combinations generally states that the product is not expected to affect the ability to drive or operate machinery.

How should Hematogen Fa be stored and disposed of?

How to Store and Dispose of Hematogen Fa

Official regulatory guidelines for Hematogen Fa detail specific storage and handling requirements necessary to maintain product quality and safety.


Storage Requirements

Condition Requirement
Temperature Store at controlled room temperature, between 15 C and 30 C (59 F and 86 F).
Prohibited Settings Avoid freezing and exposure to excessive heat (above 40 C).
Packaging Keep the product in a tightly closed container.
Child Safety Mandatory: Keep this product out of the reach of children due to the serious risk of accidental iron overdose.

Disposal

Official disposal information instructs users to contact a physician or poison control center immediately in the event of accidental overdose. Unused or expired product should be disposed of according to local pharmaceutical waste regulations, typically through authorized collection points. The product is not generally classified as hazardous or cytotoxic waste.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Hematogen Fa found in:

A-Z Index: